Oppenheimer Hosts Third Annual Immuno-Oncology Education Event at MD Anderson Cancer Center

Oppenheimer Hosts Third Annual Immuno-Oncology Education Event at MD Anderson Cancer Center

Oppenheimer & Co. Inc.  recently held its 3rd Annual Immuno-Oncology Education Event at The University of Texas MD Anderson Cancer Center and the Four Seasons Hotel in Houston on August 18-19. The event featured a number of presentations from some of immuno-oncology’s most prominent researchers, as well as one-on-one meetings with top public and private companies that are making waves in the field.

This event served as a foundation for Oppenheimer’s “On-site Insights Series,” created to give investors updated information on cancer research. “As a leader in biotechnology and life sciences equity research, we are pleased to partner with MD Anderson to offer our clients access to prominent scientists, allowing them to better understand new developments in cancer treatments and to better inform their investment decisions,” said Erica L. Moffett, Managing Director and Associate Director of Research at Oppenheimer.

Companies that participated in the event included: Affimed N.V.; Agenus Inc.; arGen-X; Armo Biosciences; Cellectis; Kite Pharma; MacroGenics, Inc.; Pieris Pharmaceuticals, Inc.; Trillium Therapeutics Inc.; Xencor, Inc.; and Zymeworks.

“Conquering cancer requires the collective effort of academia, government and the private sector,” said Ronald A. DePinho, M.D., president, MD Anderson. “To fulfill our mission to end cancer, we must convert our discoveries into lifesaving drugs through robust collaborations. We’re pleased to educate Oppenheimer’s team and their colleagues on the extraordinary advances in cancer.”

Aside from Dr. DePinho, the event also featured the a number of MD Anderson scientists including: Jim Allison, Ph.D.; Laurence Cooper, M.D., Ph.D.; Nathan Fowler, M.D.; Jeffrey Molldrem, M.D.; and Katy Rezvani, M.D., Ph.D.

Oppenheimer Research Analysts at the event included:

  • Wendy Lam, Ph.D., Senior Analyst, Biotechnology
  • Christopher Marai Ph.D., Senior Analyst, Biotechnology
  • Ling Wang, CFA, Senior Analyst, Biotechnology
  • Akiva Felt, Senior Analyst, Bio & Specialty Pharmaceuticals

Oppenheimer’s “On-site Insight Series” will take place throughout 2015 at different top ranking university research institutions nationwide. The next leg in the series is set in the Fall at the Albert Einstein College of Medicine in New York City, while its upcoming 26th Annual Healthcare Conference is scheduled December 8-9 in the same city.